LOM
TRIB

Loeb Offshore Management’s Trinity Biotech TRIB Stock Holding History

Loeb Offshore Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-81
Closed -$264K – 237
2013
Q3 		$264K Buy
+81
New +$237K 0.08% 171

Other funds holding TRIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Loeb Offshore Management's TRIB Position: Q4 2013 in Review

Loeb Offshore Management sold out of Trinity Biotech (TRIB) in Q4 2013, closing a stake of 81 shares — an estimated $264K sold.

Loeb Offshore Management first reported a position in TRIB in Q3 2013 and held it in 1 quarter. The position peaked at $264K in Q3 2013. 74 funds tracked by Wall St. Rank hold TRIB as of Q4 2013.

  • Loeb Offshore Management reported no remaining Trinity Biotech position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 81 Trinity Biotech shares in Q4 2013, an estimated $264K.
  • Loeb Offshore Management first reported a position in Trinity Biotech in Q3 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Trinity Biotech position peaked at $264K in Q3 2013.
  • 74 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.